Drägerwerk stock heads into Capital Markets Day on margin strategy
Published on 11/18/2026 at 10:04 | Editorial responsibility: Rafael Müller, Editor-in-Chief AD HOC NEWSWhat investors are watching
- Drägerwerk is holding its Capital Markets Day in Lübeck on Wednesday.
- The company is focusing on profitability, pricing and cost management across its medical and safety technology businesses.
- Dräger has raised its current 2026 EBIT margin outlook while keeping its sales growth range unchanged.
On Wednesday, November 18, 2026, Drägerwerk is holding its Capital Markets Day in Lübeck, according to the company’s financial calendar. The meeting gives investors a fresh view of how the medical and safety technology group intends to improve profitability.
Profitability remains the focus
Dräger says its medium-term priorities include stronger pricing, disciplined cost management and the restructuring or withdrawal from unprofitable activities. The group also wants to expand system solutions, services and recurring business, which could make revenue less dependent on individual product transactions.
The company’s current 2026 outlook calls for currency-adjusted sales growth of 2.0% to 6.0% and an EBIT margin of 6.0% to 8.0%. The margin range is above the earlier forecast of 5.0% to 7.5%, while the sales range remains unchanged. Dräger also expects Dräger Value Added of 60 million to 140 million euros and Days Working Capital of 100 to 105 days.
Two businesses, different tasks
Dräger operates in medical technology and safety technology. Its medical business serves acute-care hospitals, while the safety division supplies gas detection, personal protection and related services to industrial and public-sector customers. The company says future growth should come from connected medical equipment, digital applications, lifecycle services and expanded rental and safety services.
For investors, the meeting is important because execution in both divisions will determine whether the group can convert sales growth into more consistent operating earnings. Medical technology needs to improve profitability, while safety technology is being positioned for further growth in areas including defense, cleantech and data-based services.
Drägerwerk at a glance
- Company: Drägerwerk AG & Co. KGaA
- ISIN: DE0005550636
- Business: Medical and safety technology
- Headquarters: Lübeck
The DAX provides the relevant German equity-market context for investors.
